Evolution of dose distribution for a (125)I eye plaque using MCNPX and Plaque Simulator software

使用 MCNPX 和 Plaque Simulator 软件模拟 (125)I 眼部斑块的剂量分布演变

阅读:1

Abstract

OBJECTIVE: Eye plaque radiation therapy is the treatment of choice for small- and medium-sized choroidal melanomas. This study investigated the dose distribution around eye plaques containing (125)I seeds to treat ocular melanoma using Monte Carlo N-Particle eXtended (MCNPX) and Plaque Simulator (PS) software. METHODS: Dosimetry evaluation and comparison of the resulting isodose curves for (125)I COMS plaques were performed using the MCNPX code. The isodose curves and dose distributions were calculated using PS treatment planning for a (125)I COMS plaque. RESULTS: In the validation, the maximum relative difference between the results of this study and those reported in other literature was approximately 9%-10% for the COMS plaques. The dose distributions of MCNPX were lower than those of PS with a relative difference of approximately 27.7%-35.4%. The dose distribution may differ depending on the (125)I source spectra and seed design used in the two methods. In addition, the dose algorithm used in PS made a major contribution to the relative differences between the results. CONCLUSION: The PS did not provide accurate details of dose distribution near the surface of the plaque insert. The source parameters used in each program should be studied more carefully to determine the source of the differences in the estimated dose values.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。